Guardian Pharmacy Services, Inc. cash flow statement

In fiscal 2025, Guardian Pharmacy Services, Inc.'s operations generated $100m of cash; it spent $13.4m on capital projects, leaving free cash flow of $86.8m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Guardian Pharmacy Services, Inc.: cash flow statement, annual
Fiscal year	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash from operations	58	100	99
Depreciation and amortisation	20	22	23
Stock-based pay	131	14	10
Capital spending	15	13	—
Free cash flow	43	87	—
Free cash flow after stock pay	−88	73	—
Shares issued	120	29	30

US$ millions unless shown otherwise. Fiscal quarters.

Guardian Pharmacy Services, Inc.: cash flow statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	−2	22	18	20	28	35	6	30
Depreciation and amortisation	5	5	5	5	6	6	6	6
Stock-based pay	122	3	4	4	4	1	2	3
Capital spending	2	2	—	—	4	0	—	0
Free cash flow	−4	20	—	—	24	34	—	30
Free cash flow after stock pay	−127	17	—	—	20	33	—	27
Shares issued	—	0	0	29	0	0	30	0

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ADUS vs GRDN GRDN vs PIII GRDN vs HQY

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Guardian Pharmacy Services, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Guardian Pharmacy Services, Inc.